Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Pro...( Institutes to Operate in Countries A...),Health

Institutes to Operate in Countries Around the World; First Centers to Open

in Japan, U.S., France and China Kenneth P. Moritsugu, M.D., Former Acting Surgeon General, Appointed to

Lead Global Effort

NEW BRUNSWICK, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced the establishment of the Johnson & Johnson Diabetes Institute (JJDI) to transform diabetes care by providing comprehensive training on the latest practice standards, new diabetes tools and technologies and reimbursement solutions to physicians, nurses, physician assistants and diabetes educators around the globe. Former Acting U.S. Surgeon General and public health expert, Kenneth P. Moritsugu, M.D., M.P.H., will serve as the Institute's chairman.

The Institute is part of a new effort to address the growing epidemic of diabetes, which now affects more than 180 million people worldwide and is predicted to double to 360 million people by 2030. Toward this end, Johnson & Johnson affiliates will invest the necessary resources to open and operate new state-of-the-art instructional facilities worldwide, starting with Japan in 2007 and the U.S., China and France by mid-2008.

"In sheer numbers and the costs in human suffering and money spent on health care, diabetes has reached crisis proportions around the globe," said Dr. Moritsugu, who has type I diabetes and is an advocate for improved diabetes care. "At a time when the annual direct health care costs for diabetes worldwide are estimated to be at least $232 billion, new strategies are needed to raise the level of care for people with diabetes, including stepped-up education and hands-on training of health p
'/>"/>